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Efﬁcacy of chemotherapy in advanced stages of colorectal tumours is limited. The quinolone antibiotic ciproﬂoxacin was
recently shown to inhibit growth and to induce apoptosis in human bladder carcinomas cells. We investigated the effect of
ciproﬂoxacin on colon carcinoma lines in vitro. CC-531, SW-403 and HT-29 colon carcinoma and HepG2 hepatoma cells
(control cells) were exposed to ciproﬂoxacin. Proliferation was assessed by bromodeoxyuridine-incorporation into DNA and
apoptosis was measured by ﬂow cytometry after propidium iodide or JC-1 staining. Expression of anti-apoptotic Bcl-2 and
pro-apoptotic Bax was analyzed by semiquantitative Western blot analysis and activity of caspases 3, 8 and 9 by substrate-
cleavage assays. Ciproﬂoxacin suppressed DNA synthesis of all colon carcinoma cells time- and dose-dependently, whereas
the hepatoma cells remained unaffected. Apoptosis reached its maximum between 200 and 500 mgm l
71. This was
accompanied by an upregulation of Bax and of the activity of caspases 3, 8 and 9, and paralleled by a decrease of the
mitochondrial membrane potential. Ciproﬂoxacin decreases proliferation and induces apoptosis of colon carcinoma cells,
possibly in part by blocking mitochondrial DNA synthesis. Therefore, qualiﬁcation of ciproﬂoxacin as adjunctive agent for
colorectal cancer should be evaluated.
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Cancers of the colon and rectum are the most common gastroin-
testinal neoplasms, with an incidence of about 44 per 100000
per year (Boyle and Langman, 2000; Ries et al, 2000). Prognosis
and therapy are determined by tumour stage, as reﬂected by the
TNM- or the Dukes-classiﬁcation, the involvement of lymph nodes
and the presence of metastases. Operated patients with lesions
restricted to the mucosa and submucosa (Dukes A or T1N0M0)
have a 90% 5-year-survival, whereas prognosis of patients with
advanced stages of the disease (Dukes D or T1N0M0) is poor.
The ﬁrst-line treatment is radical surgical resection with local
lymph node dissection. In advanced stages of the disease, the effect
of palliative chemotherapy is limited (Midgley and Kerr, 1999;
Young and Rea, 2000).
It was recently shown that the ﬂuoroquinolone ciproﬂoxacin, a
commonly used broad-spectrum antibiotic with low side effects,
can induce time- and dose-dependent growth inhibition and apop-
tosis of bladder carcinoma (Seay et al, 1996; Ebisuno et al, 1997;
Aranha et al, 2000), osteosarcoma (Miclau et al, 1998) and
leukaemia cell lines (Some et al, 1989). Fluoroquinolone antibiotics
inhibit the bacterial type II topoisomerase/DNA gyrase which is
responsible for supercoiling, transcription, replication and chromo-
somal separation of prokaryotic DNA (Chen and Liu, 1994). How
ﬂuoroquinolone antibiotics might affect mammalian cells is still
unclear. There are no data on the effects of ﬂuoroquinolone anti-
biotics on human colon carcinoma cell proliferation and apoptosis.
We therefore investigated the anti-proliferative and pro-apoptotic
effects of ciproﬂoxacin on the colon carcinoma cell lines CC-531,
SW-403 and HT-29.
MATERIALS AND METHODS
Cell culture
CC-531 cells (rat, colorectal cancer, established from a thioaceta-
mide-induced colon carcinoma) were cultured in RPMI 1640
medium (Biochrom, Berlin, Germany) with 10% foetal calf
serum (FCS) (Gibco–BRL, Karlsruhe, Germany), penicillin
(100 U l
71), streptomycin (10 mg l
71) and ascorbic acid
(50 mg l
71)a t3 7 8C and 5% CO2. HT-29 cells (human colorec-
tal cancer, well differentiated) were cultured in the same medium
without ascorbic acid. SW-403 (human colorectal cancer, estab-
lished from a low differentiated tumour) and HepG2 (human
hepatocellular carcinoma) cells were maintained in Dulbecco’s
MEM (Biochrom) with the same additives (except ascorbic acid)
and under the same conditions. All cell lines were obtained from
the German Collection of Microorganisms and Cell Cultures
(Braunschweig, Germany). Cells were starved for 24 h in medium
containing 0.125% FCS, trypsinized (0.05% Trypsin, 0.02%
EDTA, Biochrom), seeded at a density of 0.5610
6 per well in
six-well plates (9 cm
2) (Becton Dickinson, Mannheim, Germany)
or at a density of 5610
3 per well in 96-well plates (1 cm
2) and
incubated with 100, 200 or 500 mgm l
71 ciproﬂoxacin (concen-
tration according to Aranha et al, 2000). Ciproﬂoxacin, which
was friendly provided by Bayer (Leverkusen, Germany) was
dissolved in water and further diluted in culture medium. If
not otherwise mentioned, for collection of cells supernatants were
saved after 18, 24, 48 or 72 h of incubation and centrifuged
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Further procession is described below.
Flow cytometric analysis of apoptosis
Cell death was measured by lysing cells in a hypotonic solution
containing 0.1% sodium citrate, 0.1% Triton X-100 and
50 mgm l
71 propidium iodide (Sigma, Deisenhofen, Germany)
after two washes with PBS and Trypsin-EDTA solution. Analysis
of the labelled nuclei was performed on a FACSCalibur ﬂuores-
cence-activated cell sorter (FACS) using CELLQuest software
(both from Becton Dickinson). The percentage of apoptotic cells
was determined by measuring the fraction of nuclei that contained
a sub-diploid DNA content. Ten thousand events were collected for
each sample analyzed.
BrdU-Incorporation ELISA
DNA-synthesis, which correlates well with cellular proliferation,
was measured by bromodeoxyuridine (BrdU) incorporation using
the Cell Proliferation ELISA (Roche Molecular Biochemicals,
Mannheim, Germany) based on incorporation of BrdU into newly
synthesized DNA and antibody-mediated detection of BrdU in
DNA as described (Ruehl et al, 1999). Brieﬂy, 5610
3 cells were
seeded into 96-well microtiter plates (Falcon) and incubated with
culture medium containing 10% FCS. BrdU was added to the cells
together with CIP (10
73–10
75M). After 24 h cells were ﬁxed and
DNA denatured with an ethanolic solution (30 min), followed by
incubation with an antibody to BrdU conjugated with peroxidase
(60 min, 378C). Immune complexes were detected using tetra-
methylbenzidine as substrate for 5 min, the reaction was stopped
with H2SO4 and absorption measured at 450 nm in an ELISA read-
er (MRX II, Dynex, Frankfurt, Germany). The results are given as
BrdU-incorporation (%) compared to untreated cells.
Analysis of mitochondrial membrane potential
Mitochondrial injury was assessed by JC-1 staining (MoBiTec,
Goettingen, Germany). This dye, existing as a monomer in solu-
tion emitting a green ﬂuorescence, can assume a dimeric
conﬁguration emitting red ﬂuorescence in a reaction driven by
the mitochondrial transmembrane potential (Lawrence et al,
1993; Loefﬂer and Kroemer, 2000). Thus, red ﬂuorescence of
JC-1 indicates intact mitochondria, whereas green ﬂuorescence
shows monomeric JC-1 that remained unprocessed due to break-
down of the mitochondrial membrane potential (Reers et al,
1991). After trypsinization and centrifugation (RT, 10 min,
800 r.p.m.) the cell pellet resuspended in 1 ml medium, stained
with 5 mgm l
71 JC-1 for 15 min at 378C in the dark, then washed
twice in PBS and resuspended in 0.5 ml PBS. Analysis was
performed by FACS scan and mitochondrial function was assessed
as JC-1 green (uncoupled mitochondria) or red (intact mitochon-
dria) ﬂuorescence (Smiley et al, 1991).
Assessment of caspase activity
Caspase Colorimetric Assays (R&D Systems, Minneapolis, WI,
USA) were used to determine the enzymatic activity of caspases
3, 8 and 9. The assays were performed according to the manufac-
turer’s instructions after a 24 h incubation with increasing
concentrations of ciproﬂoxacin. Caspase activation leads to the
cleavage of the provided colorimetric substrates (all substrate
peptides are conjugated to p-nitroaniline (pNA); caspase 3:
DEVD-pNA, caspase 8: IETD-pNA, caspase 9: LEHD-pNA) and
can be measured photometrically at 405 nm. According to the
manufacturer and previous publications (Sanghavi et al, 1998;
Dudich et al, 2000; Li et al, 2001) these amino acid sequences
are the preferred ones of each caspase.
Western blot analysis
Cells were lysed by adding 100 ml2 6 sample buffer (2 mM NEM,
2m M PMSF, 4% SDS, 4% DTT, 20% glycerol, 0.01% bromophe-
nol blue, 2 M urea, 0.01 M Na-EDTA, 0.15 M Tris-HCl) to
10
6 cells. DNA was sheared by pipetting up and down for
3 min at room temperature and suspensions were boiled at
958C for 15 min, centrifuged at 13000 r.p.m. for 10 min and
subjected to 14% SDS–PAGE (pre-cast gels, Novex, San Diego,
CA, USA). After blocking overnight at room temperature in a
buffer containing PBS, 0.1% Tween 20 and 4% low fat milk
powder, nitrocellulose membranes were incubated for 90 min
either with polyclonal rabbit antibodies to human Bcl-2 (1:400,
sc-783) or to human Bax (1:500, sc-493, both from Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Membranes were washed
three times for 10 min in a buffer containing PBS, 0.1% Tween
20 and 4% low fat milk powder and incubated with a goat
anti-rabbit IgG coupled to peroxidase (1:1000, Sigma, Deisenho-
fen, Germany) for 1 h at room temperature. Reactive bands were
detected with the ECL chemiluminescence reagent (Amersham
Pharmacia Biotech, Freiburg, Germany) and band intensities were
analyzed by densitometry. Normalization was performed to b-
actin.
Statistical analysis
Statistical analysis was performed using SPSS for Windows (Release
9.0.0; SPSS Inc Chicago IL, USA). Signiﬁcances were calculated
using the t-test for paired samples P50.05 was regarded as signiﬁ-
cant, P50.01 as highly signiﬁcant.
RESULTS
Morphological changes induced by ciproﬂoxacin
Figure 1 shows morphological changes observed in CC-531, SW-
403 and HT-29 cells after incubation with different concentrations
of ciproﬂoxacin for 18 h. While untreated cells grew adherent on
culture plates and were of a slender and spindle-shaped appear-
ance, cells cultured with ciproﬂoxacin detached from their
substratum, became rounded and pyknotic and showed apoptotic
bodies, thus displaying the typical morphological changes for apop-
totic cells. The control cell line HepG2 did not show comparable
morphological changes.
Ciproﬂoxacin inhibits colon carcinoma cell DNA synthesis
In CC-531 cells, incubation with ciproﬂoxacin at 100, 200 and
500 mgm l
71 for 24 h decreased the amount of BrdU incorporated
into newly synthesized DNA from 100 to 23, 12 and 9%, respec-
tively. Similar results were obtained for SW-403 and HT-29 cells.
There was no antiproliferative effect of ciproﬂoxacin on HepG2
cells (Figure 2).
Ciproﬂoxacin induces cell death in human colon carcinoma
cell lines via cell cycle arrest and mitochondrial membrane
breakdown
As evidenced by FACS-analysis of the cell cycle, ciproﬂoxacin
lead to a decrease of the G2-peak and an increase of sub-G1
events (correlates with apoptosis) (Figure 3). Time- and dose-
dependent induction of apoptosis were observed in CC-531
and HT-29 cells, while in SW-403 cells only doses of 200 and
500 mgm l
71 ciproﬂoxacin could induce signiﬁcant rates of apop-
tosis after 18, 24, 48 and 72 h. In contrast, HepG2 cells
remained largely unaffected (Table 1, Figure 4). While FACS
analysis after staining with propidium iodide only visualizes the
cell cycle, analysis after staining with JC-1 reveals the breakdown
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key process during mitochondrial-dependent apoptosis. In fact,
Figure 5 shows the increase in green vs red ﬂuorescence, indicat-
ing increased mitochondrial breakdown in CC-531 but not
HepG2 cells after 48 h of treatment with 500 mgm l
71 ciproﬂox-
acin. For HT-29 and SW-403 cells similar data were obtained
(not shown), while in HepG2 cells emitted ﬂuorescence did
not change after treatment with CIP (Figure 5). Experiments
using different concentrations of CIP and different incubation
periods showed ﬂuorescent shift in a time- and dose-dependent
manner.
Ciproﬂoxacin activates caspases 3, 8 and 9
The basal activity of caspases was set to 100% in untreated cells
and was measured after 24 h incubation with different concentra-
tions of ciproﬂoxacin. The activity of caspase 3 increased
signiﬁcantly only in CC-531 cells after incuabtion with 200 or
500 mgm l
71 CIP, while no signiﬁcant change was found in SW-
403 cells and only after incubation with 500 mgm l
71 in HepG2
cells (Figure 6). Activation of caspases 8 and 9 was dose-dependent,
with highest values after incubation with 500 mgm l
71 CIP (in SW-
403 cells). In CC-531 cells caspase-8 activity doubled after incuba-
tion with 200 and 500 mgm l
71, while in SW403 cell comparable
results were induced even by 100 mgm l
71 CIP. Caspase 9 activity
increased even more distinctly in SW-403 cells, while in CC-531
cells only the highest dose lead to signiﬁcant caspase 9 activation.
In HepG2 cells there was no change of caspase 8 activity, but
doubled activation of caspase 9 after incubation with
5200 mgm l
71 (Figure 6).
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Figure 1 Ciproﬂoxacin induces morphological signs of apoptosis in colon cancer cell lines. Colon cancer cells CC-531 (A) and SW-403 (B) as well as
hepatoma cells HepG2 (C) untreated (1) and after 18 h of incubation with 100 mgm l
71 (2) and 500 mgm l
71 (3) of ciproﬂoxacin.
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Figure 2 Ciproﬂoxacin inhibits DNA-synthesis in colon carcinoma cells.
DNA-synthesis was measured by BrdU-incorporation in CC-531, HT-29,
SW-403 and HepG2 hepatoma cells after treatment with 100, 200 or
500 mgm l
71 ciproﬂoxacin (24 h). Results for untreated cells were set at
100%. Values are means+s.d. of six independent experiments.
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(3), 443–448Pro-apoptotic Bax is upregulated by ciproﬂoxacin
Semi-quantitative Western blots were performed to investigate the
effect of ciproﬂoxacin on pro-apoptotic Bax and anti-apoptotic
Bcl-2. The ratio of Bax:Bcl-2 was set at 1.0 in untreated cells.
Bax increased dose-dependently after 3 h of incubation in all tested
cell lines, while Bcl-2 remained unchanged during the observation
time. Whereas in CC-531 cells the Bax:Bcl-2 ratio increased to 1.6,
2.3 and 5.1 with 100, 200 and 500 mgm l
71 ciproﬂoxacin, respec-
tively, only a minor response was found for SW-403 and
HepG2 cells. After 18 h, however, the Bax:Bcl-2 ratio remained
close to baseline in HepG2 cells, whereas it was highly increased
in both CC cell lines (Figure 7).
DISCUSSION
We showed that exposure of CC-531, HT-29 and SW-403 colon
carcinoma cells to ciproﬂoxacin caused a rapid suppression of de
novo DNA synthesis. Furthermore, ciproﬂoxacin potently induced
dose- and time-dependent apoptosis as shown by cell cycle analysis
and breakdown of the mitochondrial potential. In contrast, cipro-
ﬂoxacin had no or little effect on proliferation or apoptosis in the
hepatoma cell line HepG2.
Although it is assumed that ﬂuoroquinolones only inhibit
bacterial type II DNA topoisomerase/gyrase, our results conﬁrm
that they can affect the growth of certain eukaryotic cells as well.
We and others hypothesize, that these effects occur possibly via
unselective inhibition of mitochondrial DNA-synthesis with subse-
quent mitochondrial injury (Lawrence et al, 1993). Thus,
topoisomerase inhibitors might induce a selective loss of mitochon-
drial DNA, ﬁnally leading to depletion of intracellular ATP stores.
Energy depletion favours apoptosis via induction of cell cycle arrest
at the S/G2-M checkpoint, with concomitant down-regulation of
cyclin B, cyclin E, dephosphorylation of cdk2, and an up-regulation
of pro-apoptotic Bax (Jurgensmeier et al, 1998; Bratton et al,
2000). Therefore, we especially investigated the mitochondrial-
dependent events during apoptosis, such as breakdown of mito-
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Figure 3 Apoptosis is induced after 24 h of incubation with ciproﬂoxa-
cin. When compared to untreated control cells (A), incubation of SW-403
cells with 500 mgm l
71 (B) for 24 h caused a decrease of S/G2-cells (M3
and M4) and an increase of sub-G1-cells (M1) M2 marks cells in G1 phase.
Table 1 Percentage of apoptotic cells after treatment with different con-
centrations of ciproﬂoxacin for 18, 24, 48 and 72 h
Untreated 100 mgm l
71 200 mgm l
71 500 mgm l
71
18 h
CC-531 2.7+0.7 14.2+1.9* 14.7+3.3* 29.9+4.9*
HT-29 2.0+0.5 2.5+5.1 4.8+2.7 5.1+2.1
SW-403 4.9+0.8 7.0+3.7 8.8+2.0 16.9+3.2*
HepG2 3.2+1.1 3.2+1.1 4.1+0.9 3.9+0.9
24 h
CC-531 4.8+2.1 4.6+5.4 14.8+12.0* 44.6+20.5*
HT-29 5.1+1.8 4.8+3.1 5.9+2.4 8.4+4.0
SW-403 5.5+1.9 3.9+0.7 6.8+1.5 20.9+3.1*
HepG2 2.4+0.4 3.6+1.4 3.2+0.6 3.7+1.0
48 h
CC-531 4.8+1.3 10.2+0.1* 54.7+6.1* 49.8+1.1*
HT-29 1.8+0.3 2.9+0.4 6.0+5.6 12.1+3.2*
SW-403 6.7+1.0 4.2+0.6 9.6+2.5 24.3+3.4*
HepG2 3.0+0.6 3.9+0.7 4.5+0.9 3.1+0.4
72 h
CC-531 4.2+2.2 15.8+2.4 73.1+4.6* 68.2+8.4*
HT-29 7.0+4.1 2.4+1.5 15.0+2.8* 27.2+5.1*
SW-403 7.4+5.4 5.4+3.4 14.7+6.4* 31.2+5.3*
HepG2 3.1+4.7 4.0+2.8 4.5+3.5 4.1+2.3
Apoptotic cells were quantiﬁed by FACS analysis. Values are means+standard devia-
tions of three independent experiments performed in triplicate. *P50.05.
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British Journal of Cancer (2002) 86(3), 443–448 ã 2002 The Cancer Research Campaignchondrial membrane, expression of Bax and Bcl-2 and activation of
caspase 9. In fact, we observed a breakdown of the mitochondrial
membrane potential, which is most probably followed by release of
cytochrome c into the cytosol, its interaction with CED-4 like
protein Apaf-1 (Smiley et al, 1991; Jurgensmeier et al, 1998; Brat-
ton et al, 2000). The CED-4-cytochrome complex activates pro-
caspase 9 and initiates a proteolytic cascade ﬁnally leading to apop-
tosis (Smiley et al, 1991; Mancini et al, 1997; Jurgensmeier et al,
1998). Fluoroquinolone antibiotics may also trigger the Bax-path-
way of apoptosis or interfere directly with mitochondrial
membrane proteins, as described for cyclosporin A that binds to
the mitochondrial megapore (Mancini et al, 1997; Jurgensmeier
et al, 1998). Thus, activation of the mitochondrial permeability
transition pore by Bax with subsequent release of cytochrome c
has been described (Marzo et al, 1998, Narita et al, 1998). The abil-
ity of ciproﬂoxacin to activate Bax was recently shown in a bladder
carcinoma cell line (Aranha et al, 2000). Here, we observed that
ciproﬂoxacin mediates an up-regulation of Bax. Expression of
Bcl-2, which remained unchanged in our experiments, inhibits
apoptosis possibly via prevention of oxidative damage to subcellu-
lar components (Kroemer, 1997) and reduces caspase activity by
preventing the formation of pro-apoptotic bodies (Zhang et al,
1999).
Caspase 3 is activated during the process of apoptosis and is one
of the key enzymes required for the execution of the apoptotic
programme. Caspase 8 (the major caspase to be activated by the
TNF pathway) and caspase 9 (mitochondrial pathway) are initia-
tor-caspases activating the downstream effector-caspases,
especially caspase 3. Our results show signiﬁcant changes of caspase
8 and 9 in all colorectal cancer cell lines, while caspase 3 was
increased signiﬁcantly only in CC-531 cells. All changes appeared
to be dose-dependent. The observation of a well-balanced caspase
activation proﬁle in CC-531 cells and the distinctly higher activa-
tion of the initiator caspases vs caspase 3 in SW-403 cells appear
to be related to a different progression of apoptosis. Thus, after
24 h of incubation with CIP, the apoptosis rates – as shown by
FACS analysis – are higher in CC-531 than in SW-403 cells.
Our results of an increase in caspase 8 and 9 demonstrate that
CIP induces the membrane-related as well as the mitochondrial
apoptosis pathway. Similarly, hypoxia can stimulate both apoptosis
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Figure 7 Ciproﬂoxacin increases the Bax:Bcl-2 ratio time-depently in
colon cancer cells. Values of untreated cells were set to 1. Representative
Western blot showing the increase of Bax and decrease of Bcl-2 expression
in CC-531 and SW-403 cells.
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ã 2002 The Cancer Research Campaign British Journal of Cancer (2002) 86(3), 443–448pathways in lymphoma cells (Malrhota et al, 2001). Our results of
elevated bax and mitochondrial membrane potential breakdown
further indicates the CIP may primarily mediate breakdown of
mitochondrial membrane potential, while Caspase 8 is secondarily
activated. However, this needs further evaluation by using caspase
inhibitors.
In summary, we show that ciproﬂoxacin induces growth inhibi-
tion and apoptosis in colon carcinoma cell lines in a time- and
dose-dependent manner, whereas hepatoma cells remained unaf-
fected. The growth arrest is mediated through inhibition of
DNA-synthesis, induction of mitochondrial injury and subsequent
apoptosis. CIP can reach concentrations far above those of the
serum in solid tissues, such as the lung. Therefore, due to the
encouraging effects of this topoisomerase inhibitor CIP as well as
other ﬂuoroquinolones should be further investigated as (adjunc-
tive) anti-tumoural agents in colorectal cancer cells.
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